Repro-Med Systems Inc (REPR):企業の財務・戦略的SWOT分析

◆英語タイトル:Repro-Med Systems Inc (REPR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14486
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Repro-Med Systems Inc (RMS) is a medical device company that develops and manufactures home and specialty infusion solutions. The company’s products include syringe infusion system, subcutaneous safety needle sets, precision flow rate tubing, and hand held medical suction products. It offers masterson endometrial biopsy kit used for in-office biopsy sampling procedures, and thermal cautery system used for tubal ligation procedures. RMS’ products finds application in emergency care, hospital settings, nursing homes, rescue services, other medical facilities and home care, among others. The company markets its products through a network of sales representatives located across the US. RMS is headquartered in Chester, New York, the US.

Repro-Med Systems Inc Key Recent Developments

Feb 21,2019: RMS Medical Products announces hiring of Dr. Brian Schiller & plans to attend the 6th Annual BTIG Medical Technology, tools and diagnostics conference
Feb 12,2019: RMS Medical Products announces record revenue and profitability for 2018; outlines plan for continued strong growth
Feb 04,2019: RMS Medical announces new CEO, strategic plan, and upcoming schedule
Dec 06,2018: RMS Medical products announces promotion of Manny Marques to Chief Operating Officer
Dec 06,2018: RMS Medical products announces new Board Members

This comprehensive SWOT profile of Repro-Med Systems Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Repro-Med Systems Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Repro-Med Systems Inc – Key Information
Repro-Med Systems Inc – Overview
Repro-Med Systems Inc – Key Employees
Repro-Med Systems Inc – Key Employee Biographies
Repro-Med Systems Inc – Key Operational Heads
Repro-Med Systems Inc – Major Products and Services
Repro-Med Systems Inc – History
Repro-Med Systems Inc – Company Statement
Repro-Med Systems Inc – Locations And Subsidiaries
Repro-Med Systems Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Repro-Med Systems Inc – Business Description
Repro-Med Systems Inc – Corporate Strategy
Repro-Med Systems Inc – SWOT Analysis
SWOT Analysis – Overview
Repro-Med Systems Inc – Strengths
Repro-Med Systems Inc – Weaknesses
Repro-Med Systems Inc – Opportunities
Repro-Med Systems Inc – Threats
Repro-Med Systems Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Repro-Med Systems Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Repro-Med Systems Inc, Key Information
Repro-Med Systems Inc, Key Ratios
Repro-Med Systems Inc, Share Data
Repro-Med Systems Inc, Major Products and Services
Repro-Med Systems Inc, History
Repro-Med Systems Inc, Key Employees
Repro-Med Systems Inc, Key Employee Biographies
Repro-Med Systems Inc, Key Operational Heads
Repro-Med Systems Inc, Other Locations
Repro-Med Systems Inc, Subsidiaries
Repro-Med Systems Inc, Key Manufacturing facilities
Repro-Med Systems Inc, Key Competitors
Repro-Med Systems Inc, SWOT Analysis
Repro-Med Systems Inc, Ratios based on current share price
Repro-Med Systems Inc, Annual Ratios
Repro-Med Systems Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Repro-Med Systems Inc, Performance Chart
Repro-Med Systems Inc, Ratio Charts

★海外企業調査レポート[Repro-Med Systems Inc (REPR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bank of Queensland Ltd (BOQ)
    Bank of Queensland Ltd (BOQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • lululemon athletica inc.:企業の戦略・SWOT・財務情報
    lululemon athletica inc. - Strategy, SWOT and Corporate Finance Report Summary lululemon athletica inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Emerald Resources NL (EMR):企業の財務・戦略的SWOT分析
    Summary Emerald Resources NL (Emerald) is an oil and gas company that carries out mineral exploration and development. The company carries out acquisition, exploration, development and produces oil and natural gas, and gold deposits. Its projects include Okavu Gold project, and Magoffin County proje …
  • Associated Electric Cooperative Inc.:企業の発電所・SWOT分析2018
    Associated Electric Cooperative Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • MGM Resorts International:企業の戦略・SWOT・財務情報
    MGM Resorts International - Strategy, SWOT and Corporate Finance Report Summary MGM Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Arise AB (ARISE)-エネルギー分野:企業M&A・提携分析
    Summary Arise AB (Arise) is an independent onshore wind company. It has a presence in the entire value chain from prospecting and permit management to financing, construction, sale, and long-term management of its own and others’ wind farms. The company owns wind plants in southern Sweden; and co-ow …
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Compuware Corp:企業の戦略・SWOT・財務分析
    Compuware Corp - Strategy, SWOT and Corporate Finance Report Summary Compuware Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Birdstep Technology ASA:企業のM&A・事業提携・投資動向
    Birdstep Technology ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Birdstep Technology ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Samart Corporation Public Co Ltd (SAMART):企業の財務・戦略的SWOT分析
    Samart Corporation Public Co Ltd (SAMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • The Dun & Bradstreet Corporation:企業の戦略・SWOT・財務分析
    The Dun & Bradstreet Corporation - Strategy, SWOT and Corporate Finance Report Summary The Dun & Bradstreet Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Infant Bacterial Therapeutics AB (IBT B):製薬・医療:M&Aディール及び事業提携情報
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • Kenya Power and Lighting Co Ltd (KPLA):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Hatch Ltd:企業の戦略的SWOT分析
    Hatch Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Viriom Inc-製薬・医療分野:企業M&A・提携分析
    Summary Viriom Inc (Viriom) focuses on the development of antivirals for HIV treatment and prevention. The company’s lead pipeline product candidate Elpida, is a bioavailable prodrug, and VM-1500A, a non-nucleoside HIV reverse transcriptase inhibitor. Its partner portfolio includes Roche, ChemDiv, I …
  • Exandal Corp:企業の戦略・SWOT・財務分析
    Exandal Corp - Strategy, SWOT and Corporate Finance Report Summary Exandal Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ridley Corporation Ltd:企業の戦略・SWOT・財務分析
    Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hyundai Engineering & Construction Co Ltd (000720):企業の財務・戦略的SWOT分析
    Hyundai Engineering & Construction Co Ltd (000720) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Magnit:企業の戦略・SWOT・財務分析
    Magnit - Strategy, SWOT and Corporate Finance Report Summary Magnit - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • AIMM Therapeutics BV-製薬・医療分野:企業M&A・提携分析
    Summary AIMM Therapeutics BV (AIMM Therapeutics) is a biotechnology company that develops progressive approach to the discovery of therapeutic antibodies for the treatment of cancer and infectious diseases. The company offers research programs for prevention and treatment of diseases with medical ne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆